Clinical Trial Update: A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating CKD-843 for safety and efficacy in men with androgenetic alopecia; study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• CKD-843

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Androgenetic Alopecia | Phase 3 | Status: NOT_YET_RECRUITING